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Abstract 
Much debate exists over the proper course of treatment for individuals with attention-
deficit/hyperactivity disorder (ADHD). Stimulant medications, such as methylphenidate (e.g., 
Ritalin) and amphetamine (e.g., Adderall), have been shown to be effective in managing ADHD 
symptoms. More recently, non-stimulant medications, such as atomoxetine (e.g., Strattera), 
clonidine (e.g., Kapvay), and guanfacine (e.g., Intuniv), have provided a pharmacological 
alternative with potentially lesser side effects than stimulants. Behavioral therapies, like 
behavioral parent training, behavioral classroom management, and behavioral peer interventions, 
have shown long-term benefits for children with ADHD; however, the success of the short-term 
management of ADHD symptoms is not as substantial when compared with stimulant 
medications. Continued research suggests that combined treatment with active and intensive 
behavioral therapy and lower doses of stimulant medication may yield the highest ADHD 
treatment success rates. More evidence needs to be gathered to determine whether this is the 
optimal treatment plan. 
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Changing Behavior, Brain Differences, or Both? 
 Attention-deficit/hyperactivity disorder (ADHD) is a disorder that is estimated to affect 
roughly 5% of children in most cultures and manifests fairly early on in childhood (American 
Psychiatric Association, 2013). Recent studies have supported a model of the disorder with a 
unitary ADHD component and two separable and specific dimensions of inattention and 
hyperactivity-impulsivity (Burns et al., 2014; Toplak et al., 2012). This model supports the 
current view of ADHD as one single disorder with two relatively distinguishable sets of 
symptoms. The diagnostic criteria for ADHD require that symptoms from one, or both, of the 
dimensions be present before the age of twelve years (American Psychiatric Association, 2013). 
This can lead to one of three possible diagnoses: predominantly inattentive, predominantly 
hyperactive/impulsive, or combined presentation.  
In addition to the inappropriate levels of inattention, hyperactivity, and impulsivity that 
characterize individuals with ADHD, research also suggests children with ADHD face 
developmental and neuropsychological difficulties (Weyandt & Gudmundsdottir, 2014). The 
direct cause of ADHD is not yet known; however, researchers are beginning to agree on a 
multitude of factors that can contribute to a higher risk of the disorder and a greater expression of 
the symptoms.  
Etiology of ADHD 
While it is generally agreed upon that ADHD can be caused by many different factors, 
research strongly suggests that it is a neurodevelopmental disorder primarily influenced by 
genetic and neurobiological factors (Faraone, 2014; Kieling, Gonclaves, Tannock, & 
Castellanos, 2008; Scasselatti et al., 2012). In fact, a hypothesis that has seen much support as a 
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cause of ADHD is that children with ADHD show differences in brain structure and function 
compared to children without ADHD. The three brain areas that are primarily implicated in 
ADHD as showing deficits are the prefrontal cortex, the caudate nucleus, and the cerebellum 
(Sharma & Couture, 2014; Hendren, De Backer, & Pandina, 2000). 
Based on past twin studies, the evidence for there being a genetic basis for ADHD is 
becoming stronger (Swanson et al., 2000). More research needs to be done, but the genetic 
studies show that diagnosis of ADHD is associated with polymorphisms in some dopamine 
genes (Swanson, Castellanos, Murias, LaHoste, & Kennedy, 1998). These variations in 
dopamine genes have been shown to have an effect on volume of the prefrontal brain regions, 
which are often reduced in children with ADHD (Durston et al., 2005). Due largely to these 
genetic studies, ADHD is thought to have its basis in the dopaminergic system of the brain. 
Individuals with ADHD report that they cannot pay attention to topics that they find 
uninteresting, and researchers believe that a cause of this inattentiveness and distractibility 
symptom is an insufficient amount of dopamine in the prefrontal cortex (Hunt, 2006). Normal 
individuals with proper dopamine levels in the mesocortical areas have the abilities to attach 
attention and actively suppress distractions, abilities that are absent in individuals with ADHD 
(Hunt, 2006).  
Despite the strong support for brain differences as a possible cause of ADHD, the 
variation in brain structure and function between brains is often significant and the rate of brain 
development will vary even in healthy brains. However, it is generally agreed upon that ADHD 
does have its basis in biological causes. This consensus supports management of ADHD 
symptoms through the alteration of these abnormal brain discrepancies, very often through the 
employment of medication as treatment. 
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Medication Treatments 
 The use of medications to treat symptoms of ADHD in children has been debated 
heavily. Many in opposition to the use of medications argue that they are overprescribed, lead to 
overdiagnosis of ADHD, and lead to later substance use, among other contentions (Parens & 
Johnston, 2008). While concerns are valid and understandable due to the anxiety associated with 
a diagnosis in oneself or a loved one, the Council of Scientific Affairs of the American Medical 
Association found that there was little evidence of overprescription by physicians or of 
overdiagnosis or misdiagnosis of the disorder itself (Spencer, Biederman, & Wilens, 2000). Due 
to this lack of strong evidence opposing the use of medication as treatment of ADHD symptoms, 
they are often used widely and successfully in the treatment of this disorder. Historically and still 
predominantly, stimulant medications are the choice treatment. However, recent research has 
brought forth non-stimulants that are showing positive effects in the treatment of ADHD 
symptoms. 
Ritalin -- methylphenidate 
 Methylphenidate (Ritalin) has been proven effective for treatment of ADHD symptoms 
(Parker, 2013), and it is the most commonly prescribed stimulant medication (Greydanus & 
Merrick, 2009). This medication is used as a treatment of ADHD symptoms because it has been 
measured to increase the release of dopamine in target areas, such as the striatum and prefrontal 
cortex (Viggiano et al., 2004; Tripp & Wickens, 2009). Methylphenidate accomplishes this in the 
central nervous system as an indirect agonist by acting as a dopamine reuptake inhibitor to block 
the dopamine transporter. By blocking the reuptake of the monoamines dopamine and 
noradrenaline, methylphenidate increases the amount of these monoamines in the synapses in the 
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prefrontal cortex and dorsal striatal areas of the brain. The increased activation in these areas is 
widely thought to be the reason that methylphenidate works so well to ameliorate the symptoms 
of ADHD, like hyperactivity and inattentiveness.  
 Methylphenidate is approved for the treatment of ADHD symptoms in children age six or 
older in the United States (Moore, 2010). Compared to other medications—primarily non-
stimulants—methylphenidate appears to have a greater impact on ADHD symptoms, and the 
medication is generally well tolerated by children with ADHD (Bedard et al., 2015; Yildiz, 
Sismanlar, Memik, Karakaya, & Agaoglu, 2011). 
Adderall – amphetamine 
 Another common stimulant medication for the treatment of ADHD symptoms is a 
combination of the two enantiomers of amphetamine (Adderall). Methylphenidate and 
amphetamine are both seen as effective in the treatment of ADHD symptoms; however, they do 
this through slightly different mechanisms (Sharma & Couture, 2014). Both stimulant 
medications inhibit monoamine oxidase, but amphetamine is the more potent of the two (Pliszka, 
2005; Pelham et al., 1999). Research has also found that once-daily amphetamine was similar to 
twice-daily methylphenidate in its management of ADHD behavioral symptoms (Bauchner, 
2000). 
 Low doses of amphetamine are typically used initially, and the doses are gradually 
increased until the minimum dose required to produce optimal effects is found (Moore, 2010). 
Due to its higher potency, both the maximum recommended daily dose of amphetamine and the 
optimal daily dose of amphetamine are less than the suggested or required daily doses of 
methylphenidate (Findling, Short, & Manos, 2002). 
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Non-stimulant Medication Treatments 
Some individuals faced with ADHD symptoms may not respond to stimulant 
medications, they may find stimulants intolerable, or they may have an aversion toward 
stimulants because they are a controlled substance. In fact, research shows that 10-30% of all 
children and adults with ADHD either do not respond to or do not tolerate treatment with 
stimulants (Banaschewski, Roessner, Dittmann, Santosh, & Rothenberger, 2004).  
For this subset of individuals with ADHD, non-stimulant medication may be an 
alternative. FDA approved non-stimulants for the treatment of ADHD are atomoxetine 
(Strattera), extended-release α-2 agonist clonidine (Kapvay) and guanafacine (Intuniv). These 
non-stimulant medications do not have the abuse potential of stimulants, and non-stimulants are 
generally better tolerated than stimulants (Sharma & Couture, 2014). Most current research 
favors stimulant medication, but this is less due to non-stimulant inferiority—which has dubious 
support due to different study methodologies and outcome measures—and more because non-
stimulants normally take several weeks to show their full effects (Sharma & Couture, 2014). 
Atomoxetine is the best evaluated non-stimulant medication for the treatment of ADHD 
symptoms (Banaschewski et al., 2004). In a recent meta-analysis, the effectiveness of 
atomoxetine for children and youth with ADHD was shown to be effective in fifteen clinical 
trials from four different global regions (Tanaka, Rohde, Jin, Feldman, & Upadhyaya, 2013). 
The efficacy of these non-stimulant medications in comparison to stimulant medications needs to 
be examined further; however, it is becoming increasingly understood that non-stimulants 
provide an alternative treatment for ADHD symptoms. 
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Optimal Treatment of ADHD with Medication 
 Medications are not the answer or cure for the disorder. Several questions still remain 
about their long-term benefits (Jensen et al., 2007). However, their short-term benefits have been 
supported extensively in the literature (Spencer, Biederman, & Wilens, 2000). In fact, 65-75% of 
children with ADHD respond to any single medication, and this success rate can rise to 80-90% 
with the trying of a second medication for those who did not initially respond (Connor, 2014). 
In McCluskey and McCluskey’s book, one parent of a child with ADHD summed up the 
use of medications well when they said: “Ideally, stimulants should be prescribed, monitored 
carefully, and there should be ongoing communication with parents and school personnel” (cited 
in Mash & Wolfe, 2013). Medications, both stimulant and non-stimulant, are a powerful weapon 
against the symptoms of ADHD. However, like any medication, proper compliance and usage 
are important factors for this topic of treatment of ADHD symptoms. Further research needs to 
be done examining proper dosage, long-term efficacy, side effects, and the use of medication in 
both younger children and adults with ADHD.  
Nevertheless, medications are among the most effective treatments for ADHD symptoms. 
Medications do not, however, address many of the social, familial, or contextual problems that 
present themselves to children with ADHD. It is in the management of these problems that 
behavioral therapy is useful as a primary intervention. 
Behavioral Therapy 
 While medication treatment ameliorates the symptoms of ADHD in the short-term, there 
is no clear evidence that medications lead to improved long-term academic achievement 
(Pelham, 1999). However, evidence-based behavioral interventions could provide long-term 
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symptom relief. A recent literature review concluded that behavioral parent training, behavioral 
classroom management, and intensive peer-focused behavioral interventions were all well-
established treatments for children with ADHD (Pelham & Fabiano, 2008). 
Behavioral Parent Training 
 Many of the theories behind the causes of ADHD are focused on biological and genetic 
factors; however, researchers are beginning to understand how genetic susceptibility and 
environmental influences impact the development of ADHD and the exacerbation of ADHD 
symptoms (Nigg & Barkley, 2014). When considering children with ADHD, much of the 
environmental influence is due to familial or home factors, because a child is in the home 
environment frequently early on in development. It then makes sense that research suggests 
family factors and parental styles play an important role in understanding ADHD (Johnston & 
Chronis-Tuscano, 2014; Mash & Johnston, 2005). 
 Chacko et al. (2014) discuss several reasons why behavioral parent training (BPT) works 
for parents of children with ADHD. These reasons are focused on a cycle of parent-child 
behaviors. Disruptive behaviors consistent with ADHD symptoms can often cause stress and 
conflict between parents and families, while negative parental attitudes toward the child can lead 
to maladaptive parenting styles that further intensify the severity of ADHD symptom behaviors. 
It is because of this maladaptive cycle that BPT is warranted and effective for families of 
children with ADHD. 
 There are many different procedures and BPT programs; however, they mostly share a 
similar theoretical foundation based on operant and social learning theories (Garland, Hawley, 
Brookman-Frazee, & Hurlburt, 2008). The goal of most BPT programs is to provide parents with 
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a variety of skills to help them in the challenge of parenting a child with ADHD. This usually 
begins with psychoeducation. Information about ADHD, how the disorder affects the child and 
others around the child, and common treatments for the disorder all help the parents to develop 
effective parenting practices. Parents are also taught how to manage their child’s oppositional 
and noncompliant behaviors. Positive reinforcement techniques, such as specific praise and 
token reward systems, are introduced to increase the frequency of desired behaviors from the 
child. Conversely, inattention in response to attention-seeking behaviors and effective positive 
punishment, like time-out, are taught to parents to decrease the frequency of undesired behavior 
(Chacko et al., 2014; Garland et al., 2008).  
Behavioral Classroom Management 
 Other than the home and familial environment, children spend most of their time in a 
school environment. Whereas ADHD symptom behaviors can be disruptive at home, they can 
also be disruptive with teachers and classmates at school. The focus of behavioral classroom 
management (BCM) is to manage behaviors that interfere with learning and to provide an 
environment that capitalizes on the student’s strengths (DuPaul, Stoner, & Reid, 2014). 
 Many of the techniques used in BPT are also effective interventions in BCM. Positive 
reinforcement interventions, like token reward systems, and positive punishments, like time-out, 
can be used by teachers in ways similar to how a parent would use them (Chacko et al., 2014; 
Pfiffner & DuPaul, 2014; DuPaul, Stoner, & Reid, 2014). One common way for teachers to 
acknowledge student behaviors and consequently reward or punish them through a token system 
is through the use of Daily Behavior Report Cards (DBRCs) which are shown to significantly 
increase on-task behavior in children with ADHD (DuPaul, Stoner, Reid, 2014; Pfiffner & 
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DuPaul, 2014; Jurbergs, Palcic, & Kelley, 2010). A BCM intervention approach is also 
concerned with the students’ academic performance. Some evidence-based interventions that 
teachers can implement to increase the academic performance of children with ADHD are 
changing the classroom environment, actively teaching expectations, adjusting assignments, and 
adjusting instructional strategies (Pfiffner & DuPaul, 2014; DuPaul, Stoner, Reid, 2014).  
Behavioral Peer Interventions 
 Behavioral therapies such as BPT and BCM address ADHD symptoms from the 
perspectives of parents and teachers; however, peers can also have strong and essential 
interactions with children with ADHD. Disruptive behaviors and ADHD symptoms can have a 
negative effect on interpersonal relationships with peers simply due to the nature of the 
“annoying” behaviors. Individual or group-based social skills training have proven ineffective in 
producing beneficial effects for children with ADHD (Pelham & Fabiano, 2008). 
 However, intensive summer treatment programs have been shown to have a positive 
effect in targeting peer relationships and functioning in a recreational setting (Pelham & Fabiano, 
2008). These summer treatment programs are usually camp-like settings that maximize 
opportunities to build peer relationships. This type of intervention has been shown to be effective 
in producing meaningful changes in child behavior, social skills, and peer relationships (Pelham 
et al., 2010). 
Effectiveness of Behavioral Therapy in the Treatment of ADHD 
 Unlike medication treatment where the concurrent use of several different medications is 
not likely to have an additive effect on ADHD symptoms, simultaneous implementation of 
different forms of behavioral therapy does seem to be effective. Jurbergs, Palcic, and Kelley 
EFFECTIVE ADHD TREATMENT  12 
 
(2010) found that the greatest increase in on-task behavior following the use of DBRCs occurred 
in the treatment group where parents were involved in the review of the DBRC and the 
implementation of rewards for desired behavior. This additive effect of behavioral interventions 
is most often seen through the use of BPT and BCM, where home-school communication and 
cooperation concurrently reinforce desired behaviors and academic goals (DuPaul, Stoner, Reid, 
2014). The use of BPT, BCM, and BPI in conjunction with each other is an effective, evidence-
based intervention for the treatment of ADHD symptoms, because it addresses the wide array of 
environmental factors that influence, and are influenced by, children with ADHD. 
Conclusion: Effective Treatment of ADHD using both Behavioral Therapy and Medication 
 One study revealed that a stimulant medication treatment group and a combined group 
receiving both behavior therapy and stimulant medication showed significant improvement in 
ADHD symptoms, and both groups were superior to the behavior therapy only and control 
groups (MTA Study Group, 1999). However, other research has shown no significant differences 
in ADHD symptoms between a treatment group receiving behavioral therapy and a group 
receiving both behavioral therapy and stimulant medication. In this study, almost all children 
were rated as having diminished symptoms, and the treatment was seen as beneficial by parents 
of all children (Pelham et al., 2000). Pelham et al. (2000) suggested that medication did not show 
large effects beyond behavioral intervention when the behavioral intervention was active and 
intensive.  
Furthermore, concurrent behavioral intervention diminished the incremental effects of 
stimulant medications beyond low to moderate doses (Pelham et al., 1999; Dopfner et al., 2004). 
Pelham et al. (1999) showed an increased effect of stimulant medication beyond behavioral 
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intervention; however, it suggests that lower doses of the medication are needed when used in 
conjunction with effective behavioral therapy. In one study that examined individually tailored 
adaptive and multimodal intervention for children with ADHD, researchers found evidence that 
high success rates could be found after combined treatment, even if separate behavioral therapy 
or medication treatment had been less effective (Dopfner et al., 2004). Yet another researcher 
concluded that medications should be used as part of a larger intervention plan for children with 
ADHD, along with things like behavioral parent training and school consultation (Connor, 
2014). 
 Medications may be preferred in the short-term management of ADHD symptoms, but 
proper and intensive behavioral therapy receives much support in the literature as a long-term 
treatment for improving the symptoms of ADHD. Recent literature shows the merits of 
combined behavioral therapy and medication intervention (Smith & Shapiro, 2014). It may very 
well be the case that treatment plans need to be carefully individualized and optimized for each 
individual with ADHD. Clearly, much more research needs to be done to determine the optimal 
treatment plan for children with ADHD. 
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